| Name | Title | Contact Details |
|---|
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
We ensure all people impacted by cancer are empowered by knowledge, strengthened by action and sustained by community.
Mauna Kea Technologies is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Appalachian Regional Healthcare is a healthcare system with 11 hospitals, multi-specialty physician practices, home health agencies, HomeCare Stores, and retail pharmacies. They provide care close to home for 350,000 residents in Central Appalachia.
BERTRAND CHAFFEE HOSPITAL is a Springville, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.